| Price | Rs 74.99 |
| ZEME fair value | Rs 51.25 |
| Discount to fair value | -31.7% |
| Smart-money phase | Watching |
| Confidence score | 36/100 |
| RSI (14) | 36.8 |
| P/E | 15.6 |
| ROE | —% |
| Dividend yield | 4.7% |
| 52-week range | Rs 70.14 – Rs 101.77 |
| Sector | Pharmaceuticals |
| Shariah-compliant | Yes ☪ |
CPHL (Citi Pharma Ltd) trades at Rs 74.99 on the Pakistan Stock Exchange, in the Watching smart-money phase — neutral. ZEME's model puts fair value near Rs 51.25, making it about 31.7% overvalued. No decisive smart-money footprint yet — one to watch, not chase.
ZEME AI reads CPHL through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.
Neutral — no decisive smart-money signal yet; better setups may exist. No decisive smart-money footprint yet — one to watch, not chase. As of 20 Jul 2026, CPHL is in the Watching phase with a ZEME confidence score of 36/100.
ZEME estimates CPHL's fair value at about Rs 51.25, versus a market price of Rs 74.99 — roughly 31.7% overvalued.
CPHL is currently in the Watching phase. No decisive smart-money footprint yet — one to watch, not chase.
Data updated 20 Jul 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.